updated 3/4/2011 6:48:44 PM ET 2011-03-04T23:48:44

SEATTLE, March 4, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), wishes to provide a clarification to the Press Release issued on March 1, 2011 'TapImmune Closes $1.16 Million Funding'.

We mistakenly stated in the footnote 'About TapImmune' section that "TapImmune is in clinical development of a vaccine technology to treat HER-2/neu positive breast cancer." Our statement should have read "TapImmune is in pre-clinical development of a vaccine technology to treat HER-2/neu positive breast cancer."

Forward-Looking Statement Disclaimer

This release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this news release concerning the Company's expectations, plans, business outlook or future performance, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements." Forward-looking statements are by their nature subject to risks, uncertainties and other factors which could cause actual results to differ materially from those stored in such statements. Such risks, uncertainties and factors include, but are not limited to the risks set forth in the Company's most recent Form 10-K and other SEC filings which are available through EDGAR at www.sec.gov. The Company assumes no obligation to update the forward-looking statements.

The TapImmune Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3877

CONTACT: Glynn Wilson, Chairman & CEO
         Taplmmune Inc.
         (866) 359-7541
         Investor Relations (800) 953-3350

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com